ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,049.24
0.88%
US Tech 100
21,104.80
1.13%
Dow Jones
44,025.81
1.24%
Brent Oil
78.37
-0.48%
Bitcoin
105,445.86
-0.68%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Opus Genetics Inc (IRD) Quote

Opus Genetics Inc

Opus Genetics Inc (IRD)

Iron Road Limited
1.15
0.02
(1.77%)
Closed January 22 4:00PM
Delayed by 15 minutes
1.14
-0.01
(-0.87%)
After Hours: 7:07PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
1.14
Bid
1.12
Ask
1.21
Volume
128,073
1.12 Day's Range 1.2109
0.81 52 Week Range 1.56
Market Cap
35.988M
Previous Close
1.13
Open
1.12
Last Trade
20
@
1.1886
Last Trade Time
Financial Volume
$ 146,766
VWAP
1.146
Average Volume (3m)
233,046
Shares Outstanding
31,568,457
Dividend Yield
-
PE Ratio
-5.72
Earnings Per Share (EPS)
-0.32
Revenue
19.05M
Net Profit
-9.99M

About Opus Genetics Inc

Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting front and back of the eye indications. The Nyxol ... Ocuphire Pharma Inc is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Ocuphire's pipeline includes two small molecular product candidates targeting front and back of the eye indications. The Nyxol candidate is being developed for dim light or night vision disturbances, reversal of pharmacologically induced mydriasis, and presbyopia. The second product candidate, APX3330, is being developed for diabetic retinopathy and diabetic macular edema. Show more

Sector
Motion Pic, Videotape Prodtn
Industry
Pharmaceutical Preparations
Website
www.ocuphire.com
Headquarters
Wilmington, Delaware, USA
Founded
1999
Opus Genetics Inc is listed in the Motion Pic, Videotape Prodtn sector of the NASDAQ with ticker IRD. The last closing price for Opus Genetics was $1.13. Over the last year, Opus Genetics shares have traded in a share price range of $ 0.81 to $ 1.56.

Opus Genetics currently has 31,568,457 shares outstanding. The market capitalization of Opus Genetics is $35.67 million. Opus Genetics has a price to earnings ratio (PE ratio) of -5.72.

Ask ADVFN Intelligence (AI)

IRD Latest News

More News
No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.09-7.317073170731.231.311.121053001.1595513CS
40.1312.87128712871.011.560.96852475131.24186088CS
12-0.22-16.17647058821.361.560.812330461.1044547CS
26-0.05-4.201680672271.191.560.812315801.10991715CS
52-0.05-4.201680672271.191.560.812315801.10991715CS
156-0.05-4.201680672271.191.560.812315801.10991715CS
260-0.05-4.201680672271.191.560.812315801.10991715CS

IRD - Frequently Asked Questions (FAQ)

What is the current Opus Genetics share price?
The current share price of Opus Genetics is $ 1.14
How many Opus Genetics shares are in issue?
Opus Genetics has 31,568,457 shares in issue
What is the market cap of Opus Genetics?
The market capitalisation of Opus Genetics is USD 35.67M
What is the 1 year trading range for Opus Genetics share price?
Opus Genetics has traded in the range of $ 0.81 to $ 1.56 during the past year
What is the PE ratio of Opus Genetics?
The price to earnings ratio of Opus Genetics is -5.72
What is the cash to sales ratio of Opus Genetics?
The cash to sales ratio of Opus Genetics is 3
What is the reporting currency for Opus Genetics?
Opus Genetics reports financial results in USD
What is the latest annual turnover for Opus Genetics?
The latest annual turnover of Opus Genetics is USD 19.05M
What is the latest annual profit for Opus Genetics?
The latest annual profit of Opus Genetics is USD -9.99M
What is the registered address of Opus Genetics?
The registered address for Opus Genetics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Opus Genetics website address?
The website address for Opus Genetics is www.ocuphire.com
Which industry sector does Opus Genetics operate in?
Opus Genetics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ASSTAsset Entities Inc
$ 0.8998
(93.71%)
262.98M
DWTXDogwood Therapeutics Inc
$ 3.18
(70.05%)
24.28M
USEGUS Energy Corp
$ 3.74
(61.21%)
107.77M
DOGZDogness International Corporation
$ 27.62
(52.60%)
1.93M
MYNAMynaric AG
$ 0.6697
(50.83%)
3.72M
GOEVCanoo Inc
$ 0.3748
(-72.24%)
41.38M
SHOTWSafety Shot Inc
$ 0.1094
(-47.40%)
18.06k
ORKTOrangeKloud Technology Inc
$ 0.7068
(-36.89%)
7.48M
HEPAHepion Pharmaceuticals Inc
$ 0.3219
(-31.36%)
1.66M
WNWMeiwu Technology Company Ltd
$ 0.2681
(-27.05%)
11.02M
GCTKGlucoTrack Inc
$ 0.1226
(44.41%)
613.28M
CRKNCrown Electrokinetics Corporation
$ 0.1121
(-10.32%)
392.52M
ASSTAsset Entities Inc
$ 0.8998
(93.71%)
262.98M
RIMEAlgorhythm Holdings Inc
$ 0.034599
(-16.83%)
230.08M
RGTIRigetti Computing Inc
$ 13.97
(42.12%)
226.81M

Discussion

View Full Feed
i_dont_know i_dont_know 5 minutes ago
Probably the best choice. Invest you money in AI related tech, this will boom for the next years, thanks to trump. I will offset my AI gains with my BLPG loss, when I ll sell my tech stocks. Yeah Blpg was a waste of money and time.
BLPG
4retire 4retire 5 minutes ago
More for us to buy
NVDA
jeunke22 jeunke22 6 minutes ago
I have asked if there was a plan B and got confirmation. I understand that the current plan is financially more favorable and therefore pursued. Don’t shoot the messenger.
Really anxious to see if Trump will be able to get this project finally move into gear.
NB
StockHobit StockHobit 10 minutes ago
Looks like legal battle is over and Kate won.  
CEOS
TimeIsFading TimeIsFading 12 minutes ago
I hope they all saw it. I posted about news coming soon over an hour before that tweet. There will be multiple news coming out that's huge and it's tough not to say what, but I must abide by my NDA. Just be happy to have shares down here 😉
https://x.com/CryptoTimeFadin/status/1881943
KRTL
Pickme2 Pickme2 14 minutes ago
Ok...show me where the filings are audited...I showed you facts they are  unaudited!!!..

ATMH
Wolf-man jack Wolf-man jack 16 minutes ago
WQLF SAYS; It appears that not too many folks realize how important this acquisition along with Elevated Softgels is for CVSI investors ….. We will be not only be saving in costs of manufacturing, possible headquarters, less state taxes, etc But also revenue from manufacturing for other companies. H
CVSI
wagner wagner 16 minutes ago
https://www.whitehouse.gov/presidential-actions/2025/01/unleashing-american-energy/

Coming closer.... Bigger audience?

Some fire in the smoke??



NB
Dodger1 Dodger1 16 minutes ago
..and you wonder why people with the underlying love do not care, yet you have Ms.Underwood delivering ..

Takers and Givers...

AABB imo is a Giver! Carey...you too!

Go $AABB
AABB
Fully Diluted Fully Diluted 16 minutes ago
Hi Angelmin,

I hope your first impression misleads you. I don't think Bessent will have to fight for an end to conservatorships. I also believe that he will do whatever Trump asks him to do. That's what he said three times during the confirmation hearing.
FNMA
georgejjl georgejjl 17 minutes ago
https://cslide.ctimeetingtech.com/adpd25/attendee/person/13623

Good luck and GOD bless,
AVXL
TimeIsFading TimeIsFading 22 minutes ago
No that's way off. Not sure where that information is coming from, but it's certainly not what's happening with KRTL. It looked like you've been following the developments, so I'm surprised you wouldn't know that. If it gave the real business summary with everything happening right now and yet to be
KRTL
Pickme2 Pickme2 23 minutes ago
So ....doesn't mean anything and they just filled unaudited filings!!!! "UNAUDiTED " 
ATMH
Fully Diluted Fully Diluted 24 minutes ago
Hi Ace Trader,

You and Rick were obviously ahead of me. No question that conservatorships will end under Bessent.

I like this answer best:
Question 71: Should the Trump Administration bar any individuals or entities who would
financially profit from the en
FNMA
Konaploinks Konaploinks 24 minutes ago
Yes I did. Michio is a stand up guy. Great writer. Way ahead of his time.
IONQ
Pickme2 Pickme2 26 minutes ago
Yes and clearly on the filings they are not audited... they helped prepare documents for the management to submit....nice try...remember disclosure...intend don't mean they did!!! And per filings they did NOT
Same as with the up listing...they intend to....protecting by forward looking statem
ATMH
midastouch017 midastouch017 29 minutes ago
BioLineRx Issues Letter to Shareholders

- Company outlines strategic long-term vision and financial outlook -

TEL AVIV, Israel -- January 21, 2025 – BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncolo
BLRX PDAC
pantherj pantherj 31 minutes ago
There were, I would think, some "one off" circumstances that effected the report. I would hope and believe, that the company has a much more clear sailing in 2025.
Pickme2 Pickme2 33 minutes ago
No it is not...states right on the filings clearly unaudited, done by management... Learn to read...fool
ATMH
eb0783 eb0783 35 minutes ago
"Having some clients they are working with" is a good point. My first thought reading the pr was: where are the resources/ funding coming from for this big development.
GDVM
pantherj pantherj 35 minutes ago
We all know that the CERO of this scam is a filthy, dirty lying scum bag. His only skill in life is defrauding others.
MRNJ

Your Recent History

NASDAQ
IRD
Opus Genetics
USOTC
MONGF
Montego Resources (PK)
BIT
O8JP55
Morgan Stanley BV
BIT
UC5F53
Unicredit Bank
BIT
UC914U
Unicredit Bank
BIT
P1F317
BNP Paribas Issuance
BIT
UC7XES
Unicredit Bank
BIT
P1SXN8
BNP Paribas Issuance
BIT
UB87PA
Unicredit Bank
BIT
P1SLI3
BNP Paribas Issuance
BIT
FINSW
ETF
BIT
IN4
Industrial Stars Of Ital...
BOV
RPAD6Q
ALFA PNB
BIT
P1PUT7
BNP Paribas Issuance
BIT
UC7WK9
Unicredit Bank
BIT
UC92U8
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads